Gilde Healthcare

Activity from announced rounds

Activity in this selectionUnited States · Oct 23, 2026 · Jan 1, 2026
Rounds participated in
3
Confirmed lead rounds
—
3 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$203.7M
3 disclosed · full round size, not this investor’s share

By stage

Series C+2
Undisclosed1

By primary sector

Healthtech3

By country

United States3

Rounds

3 in this selection
GT Medical Technologies

Develops bioresorbable radiotherapy implants for surgical treatment of operable brain tumors

$100MSeries E
Role not disclosed
Big Health

Provides digital treatments for insomnia, anxiety, and depression

$23.7MUndisclosed
Role not disclosed